Testing effectiveness (Phase 2)Study completedNCT02301897
What this trial is testing
A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 43